Intrinsiqs

Is Rigel Pharmaceuticals, Inc. overvalued?

Rigel Pharmaceuticals, Inc. (RIGL) looks undervalued — trading about 140% below its fair value.

Undervalued
Current price $44.46 Fair value $106.87
Price
$44.46
Fair value
$106.87
Current P/E
7.0
Normal P/E
16.9
Market cap
$837.2M
Dividend yield
0.0%
Return on equity
73.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares RIGL's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.